Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Albuminuria as a marker of systemic congestion in patients with heart failure( )
Boorsma, E. M., Ter Maaten, J. M., Damman, K., van Essen, B. J., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Dickstein, K., Metra, M., Filippatos, G., Lang, C. C., Ng, L., Anker, S. D., Cleland, J. G., Pellicori, P., Gansevoort, R. T., Heerspink, H. J. L., Voors, A. A. & Emmens, J. E., 1-Feb-2023, In: European Heart Journal. 44, 5, p. 368-380 13 p., ehac528.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)6 Downloads (Pure) -
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Schnell, O., Battelino, T., Bergenstal, R., Birkenfeld, A. L., Ceriello, A., Cheng, A., Davies, M., Edelman, S., Forst, T., Giorgino, F., Green, J., Groop, P. H., Hadjadj, S., J.L.Heerspink, H., Hompesch, M., Izthak, B., Ji, L., Kanumilli, N., Mankovsky, B., Mathieu, C., & 16 others, 16-Mar-2023, (E-pub ahead of print) In: Cardiovascular Diabetology. 22, 1, 12 p., 59.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile1 Downloads (Pure) -
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)
Green, J. B., Mottl, A. K., Bakris, G., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Nangaku, M., Rossing, P., Scott, C., Gay, A. & Agarwal, R., Apr-2023, In: Nephrology Dialysis Transplantation. 38, 4, 10 p., gfac198.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Citations (Scopus)141 Downloads (Pure) -
Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease
Gregorich, M., Kammer, M., Heinzel, A., Böger, C., Eckardt, K. U., Heerspink, H. L., Jung, B., Mayer, G., Meiselbach, H., Schmid, M., Schultheiss, U. T., Heinze, G. & Oberbauer, R., 5-Apr-2023, In: Jama network open. 6, 4, 13 p., E231870.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)1 Downloads (Pure) -
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study
Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, P., Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., Mar-2023, In: Diabetes Care. 46, 3, p. 602-607 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Activities
-
ASN Kidney week
Hiddo Lambers Heerspink (Speaker)
7-Nov-2019 → 9-Nov-2019Activity: Talk and presentation › Academic presentation › Academic
-
Asian-Australian Diabetes Meeting
Hiddo Lambers Heerspink (Invited speaker)
24-Aug-2019Activity: Talk and presentation › Academic presentation › Academic
-
Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas
Jasper Stevens (Speaker) & Hiddo Heerspink (Speaker)
29-Jan-2019Activity: Talk and presentation › Professional or public presentation › Professional
-
European Association for the Study of Diabetes (EASD) Barcelona 2019
Hiddo Lambers Heerspink (Invited speaker)
17-Sept-2019Activity: Talk and presentation › Academic presentation › Academic
-
Invited lecture at SGLT2 inhibition and the kidney
Hiddo Lambers Heerspink (Speaker)
Feb-2018Activity: Talk and presentation › Professional or public presentation › Professional
Datasets
-
Additional file 3 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Puppala, S. (Contributor), de Zeeuw, D. (Contributor), Sourbron, S. (Contributor), Banks, R. E. (Contributor), Lienczewski, C. (Contributor), Papale, M. (Contributor), Metsärinne, K. (Contributor), Andress, D. (Contributor), Gomez, M. F. (Contributor), Kretzler, M. (Contributor), Tobin, K. (Contributor), Garcia Hernandez, A. (Contributor), Shore, A. C. (Contributor), Gilmour, P. S. (Contributor), Saunavaara, V. (Contributor), Lambers Heerspink, H. (Contributor), Teh, I. (Contributor), Gesualdo, L. (Contributor), Ibberson, M. (Contributor), Shelley, D. (Contributor), Koivuviita, N. (Contributor), Pontrelli, P. (Contributor), Grenier, N. (Contributor), Karihaloo, A. (Contributor), Nuutila, P. (Contributor), Dutius Andersson, A. (Contributor), Welberry Smith, M. (Contributor), Mansfield, M. (Contributor), Sharma, K. (Contributor), Gooding, K. M. (Contributor), Ball, C. (Contributor), Bailey, J. (Contributor), Gilchrist, M. (Contributor), Zetterqvist, A. (Contributor) & Maziarz, M. (Contributor), University of Groningen, 29-Jun-2020
DOI: 10.6084/m9.figshare.12586634.v1
Dataset
-
Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Lienczewski, C. (Contributor), Karihaloo, A. (Contributor), Kretzler, M. (Contributor), Dutius Andersson, A. (Contributor), Pontrelli, P. (Contributor), Gesualdo, L. (Contributor), Sharma, K. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Shore, A. C. (Contributor), Ibberson, M. (Contributor), Lambers Heerspink, H. (Contributor), Gomez, M. F. (Contributor), Gilchrist, M. (Contributor), Nuutila, P. (Contributor), Teh, I. (Contributor), Mansfield, M. (Contributor), Papale, M. (Contributor), Banks, R. E. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Tobin, K. (Contributor), Metsärinne, K. (Contributor), Zetterqvist, A. (Contributor), Garcia Hernandez, A. (Contributor), de Zeeuw, D. (Contributor), Ball, C. (Contributor), Grenier, N. (Contributor), Saunavaara, V. (Contributor), Maziarz, M. (Contributor), Gilmour, P. S. (Contributor), Shelley, D. (Contributor) & Puppala, S. (Contributor), University of Groningen, 29-Jun-2020
DOI: 10.6084/m9.figshare.12586625.v1
Dataset
-
Additional file 4 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Pontrelli, P. (Contributor), Grenier, N. (Contributor), Sharma, K. (Contributor), Dutius Andersson, A. (Contributor), Garcia Hernandez, A. (Contributor), Mansfield, M. (Contributor), Teh, I. (Contributor), de Zeeuw, D. (Contributor), Lambers Heerspink, H. (Contributor), Ibberson, M. (Contributor), Papale, M. (Contributor), Saunavaara, V. (Contributor), Shore, A. C. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Lienczewski, C. (Contributor), Banks, R. E. (Contributor), Metsärinne, K. (Contributor), Gilmour, P. S. (Contributor), Maziarz, M. (Contributor), Tobin, K. (Contributor), Shelley, D. (Contributor), Gesualdo, L. (Contributor), Puppala, S. (Contributor), Kretzler, M. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Nuutila, P. (Contributor), Gilchrist, M. (Contributor), Karihaloo, A. (Contributor), Ball, C. (Contributor), Zetterqvist, A. (Contributor) & Gomez, M. F. (Contributor), University of Groningen, 29-Jun-2020
DOI: 10.6084/m9.figshare.12586637.v1
Dataset
-
Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Levin, A. (Contributor), Greene, T. (Contributor), de Zeeuw, D. (Contributor), Edwards, R. (Contributor), Pollock, C. (Contributor), Zhang, H. (Contributor), Lambers Heerspink, H. (Contributor), Bakris, G. L. (Contributor), Desai, M. (Contributor), Agarwal, R. (Contributor), Neal, B. (Contributor), Jardine, M. J. (Contributor), Zinman, B. (Contributor), Cannon, C. P. (Contributor), Perkovic, V. (Contributor), Bull, S. (Contributor), Brenner, B. M. (Contributor), Mahaffey, K. W. (Contributor), Wheeler, D. C. (Contributor), Charytan, D. M. (Contributor) & Xie, J. (Contributor), University of Groningen, 13-Dec-2017
DOI: 10.6084/m9.figshare.5696959.v1, https://doi.org/10.6084%2Fm9.figshare.5696959.v1
Dataset
-
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
Eder, S. (Contributor), Leierer, J. (Contributor), Kerschbaum, J. (Contributor), Rosivall, L. (Contributor), Wiecek, A. (Contributor), de Zeeuw, D. (Contributor), Mark, P. B. (Contributor), Heinze, G. (Contributor), Rossing, P. (Contributor), Lambers Heerspink, H. (Contributor) & Mayer, G. (Contributor), University of Groningen, 21-Feb-2018
DOI: 10.6084/m9.figshare.5909164.v1
Dataset
Press/Media
-
A Study to Assess the Effects of Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
05/10/2022
1 item of Media coverage
Press/Media: Research › Popular
-
Diabetes drug can slow kidney function decline, study finds
05/07/2022
1 item of Media coverage
Press/Media: Research › Academic
-
Dapagliflozin did not reduce risks in patients hospitalized with COVID-19
29/04/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Does the Drug Dapagliflozin Benefit Hospitalized Patients with Covid-19?
29/04/2022
2 Media contributions
Press/Media: Expert Comment › Professional
-
La dapagliflozina no reduce los riesgos en los pacientes hospitalizados con COVID-19
29/04/2022
1 Media contribution
Press/Media: Expert Comment › Popular